Nursing Times’ new, open access, learning unit will teach nurses when and how to report suspected adverse drug reactions ...

The MHRA has released statistics on its pharmacovigilance inspections ... a serious violation of applicable legislation and guidelines. The most prevalent critical finding was reference safety ...

Guidelines on the treatment of ADHD, issued by the National Institute for Health and Clinical Excellence (NICE) in 2008 and updated in July 2013, state that drug treatment is not always first-line ...

The UK regulatory agency said that future updates may extend the guidance to other personalised therapies, including treatments for rare diseases. June Raine, MHRA’s CEO said: “As an enabling ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The U.K. is continuing to shape up regulation, adding reform of its accelerated drug approval process and its draft guidance on personalized mRNA cancer vaccines to new clinical trial regulations that ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on meeting UK medical devices regulations in the development of digital mental health technologies. The move is ...

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...